The biology of VEGF and its receptors
- PMID: 12778165
- DOI: 10.1038/nm0603-669
The biology of VEGF and its receptors
Abstract
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. VEGF has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions. The biological effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties. Non-signaling co-receptors also modulate VEGF RTK signaling. Currently, several VEGF inhibitors are undergoing clinical testing in several malignancies. VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.
Similar articles
-
Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.IDrugs. 2003 Mar;6(3):224-31. IDrugs. 2003. PMID: 12789611 Review.
-
Vascular endothelial growth factor and the regulation of angiogenesis.Recent Prog Horm Res. 2000;55:15-35; discussion 35-6. Recent Prog Horm Res. 2000. PMID: 11036931 Review.
-
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.Haematologica. 2003 Feb;88(2):176-85. Haematologica. 2003. PMID: 12604407
-
Double _target for tumor mass destruction.J Clin Invest. 2003 May;111(9):1277-80. doi: 10.1172/JCI18539. J Clin Invest. 2003. PMID: 12727916 Free PMC article. No abstract available.
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.Nat Med. 2001 May;7(5):569-74. doi: 10.1038/87895. Nat Med. 2001. PMID: 11329058
Cited by
-
Combinatorial treatment with traditional medicinal preparations and VEGFR-tyrosine kinase inhibitors for middle-advanced primary liver cancer: A systematic review and meta-analysis.PLoS One. 2024 Nov 22;19(11):e0313443. doi: 10.1371/journal.pone.0313443. eCollection 2024. PLoS One. 2024. PMID: 39576764 Free PMC article.
-
Knockdown of the long noncoding RNA VSIG2-1:1 promotes the angiogenic ability of human pulmonary microvascular endothelial cells by activating the VEGF/PI3K/AKT pathway.Respir Res. 2024 Nov 20;25(1):412. doi: 10.1186/s12931-024-03039-y. Respir Res. 2024. PMID: 39568008 Free PMC article.
-
Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report.Oncol Lett. 2024 Nov 11;29(1):52. doi: 10.3892/ol.2024.14798. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39564374 Free PMC article.
-
Catalpol regulates apoptosis and proliferation of endothelial cell via activating HIF-1α/VEGF signaling pathway.Sci Rep. 2024 Nov 16;14(1):28327. doi: 10.1038/s41598-024-78126-7. Sci Rep. 2024. PMID: 39550364 Free PMC article.
-
Recent advances in surface functionalization of cardiovascular stents.Bioact Mater. 2024 Oct 28;44:389-410. doi: 10.1016/j.bioactmat.2024.10.025. eCollection 2025 Feb. Bioact Mater. 2024. PMID: 39539518 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
